肯尼亚的莱什曼病:诊断的范围审查子分析
Katherine O'Brien1,2, Grace Grifferty2,3, Hugh Shirley2,4
1Department of Public Health and Health Sciences, Northeastern University, Boston, Massachusetts, USA obrien.kather@northeastern.edu.
BMJ open
|October 13, 2025
概括
在肯尼亚,准确诊断莱什曼病至关重要. 本次审查突出了诊断工具的研究缺陷,强调需要更新和验证的方法来有效管理莱什曼病例.
科学领域:
- 被忽视的热带疾病研究研究
- 医疗诊断发展发展 医疗诊断发展
- 公共卫生干预措施 公共卫生干预措施
背景情况:
- 莱什曼病是肯尼亚的一个重大公共卫生问题,需要精确的诊断方法来有效管理和治疗.
- 准确和及时的诊断对于利什曼病消除策略至关重要.
- 这项研究扩展了之前的工作,特别关注肯尼亚的诊断研究格局.
研究的目的:
- 在肯尼亚对莱什曼病诊断工具的现有研究进行全面审查和总结.
- 在肯尼亚背景下,确定目前莱什曼病诊断研究中的关键缺口.
- 为未来的研究方向提供信息,以改善肯尼亚的莱什曼病诊断.
主要方法:
- 采用了一个范围审查方法,基于肯尼亚莱什曼病的先前范围审查.
- 在多个主要数据库 (PubMed,Embase,Web of Science,Cochrane Library) 和临床试验注册表中进行了广泛的文献搜索.
- 该搜索包括到2024年1月5日发表的研究,特别关注诊断研究.
主要成果:
- 经过严格的查,检查各种诊断工具后,包括了41项研究.
- 对于皮肤莱什曼病和卡拉阿扎尔后皮肤莱什曼病诊断等特定形式的研究存在显著的缺乏.
- 缺口包括实时PCR的有限评估,关于直接聚合测试的过时文献,以及诊断工具随机试验的稀缺性.
结论:
- 未来的研究必须优先考虑在肯尼亚的流行病学背景下验证和完善诊断工具.
- 显然需要更新现有文献,并进行新的随机试验以提高诊断准确度.
- 加强莱什曼病诊断的证据基础对于改善肯尼亚患者的治疗结果和疾病控制至关重要.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.9K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.7K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
